Macarron R - Search Results

1

A standard operating procedure for assessing liquid handler performance in high-throughput screening.

Taylor PB, Ashman S, Baddeley SM, Bartram SL, Battle CD, Bond BC, Clements YM, Gaul NJ, McAllister WE, Mostacero JA, Ramon F, Wilson JM, Hertzberg RP, Pope AJ, Macarron R. Taylor PB, et al. Among authors: macarron r. J Biomol Screen. 2002 Dec;7(6):554-69. doi: 10.1177/1087057102238630. J Biomol Screen. 2002. PMID: 14599354

2

Design and implementation of high throughput screening assays.

Macarrón R, Hertzberg RP. Macarrón R, et al. Methods Mol Biol. 2002;190:1-29. doi: 10.1385/1-59259-180-9:001. Methods Mol Biol. 2002. PMID: 12029816

3

Design and implementation of high-throughput screening assays.

Macarrón R, Hertzberg RP. Macarrón R, et al. Methods Mol Biol. 2009;565:1-32. doi: 10.1007/978-1-60327-258-2_1. Methods Mol Biol. 2009. PMID: 19551355

4

Design and implementation of high throughput screening assays.

Macarrón R, Hertzberg RP. Macarrón R, et al. Mol Biotechnol. 2011 Mar;47(3):270-85. doi: 10.1007/s12033-010-9335-9. Mol Biotechnol. 2011. PMID: 20865348 Review.

5

Process validation and screen reproducibility in high-throughput screening.

Coma I, Clark L, Diez E, Harper G, Herranz J, Hofmann G, Lennon M, Richmond N, Valmaseda M, Macarron R. Coma I, et al. Among authors: macarron r. J Biomol Screen. 2009 Jan;14(1):66-76. doi: 10.1177/1087057108326664. J Biomol Screen. 2009. PMID: 19171922

6

Impact of high-throughput screening in biomedical research.

Macarron R, Banks MN, Bojanic D, Burns DJ, Cirovic DA, Garyantes T, Green DV, Hertzberg RP, Janzen WP, Paslay JW, Schopfer U, Sittampalam GS. Macarron R, et al. Nat Rev Drug Discov. 2011 Mar;10(3):188-95. doi: 10.1038/nrd3368. Nat Rev Drug Discov. 2011. PMID: 21358738 Review.

7

The effect of triton concentration on the activity of undecaprenyl pyrophosphate synthase inhibitors.

Li H, Huang J, Jiang X, Seefeld M, McQueney M, Macarron R. Li H, et al. Among authors: macarron r. J Biomol Screen. 2003 Dec;8(6):712-5. doi: 10.1177/1087057103258185. J Biomol Screen. 2003. PMID: 14711397

8

Novel antibacterials: a genomics approach to drug discovery.

Chan PF, Macarron R, Payne DJ, Zalacain M, Holmes DJ. Chan PF, et al. Among authors: macarron r. Curr Drug Targets Infect Disord. 2002 Dec;2(4):291-308. doi: 10.2174/1568005023342227. Curr Drug Targets Infect Disord. 2002. PMID: 12570737 Review.

9

Identification and biological characterization of heterocyclic inhibitors of the hepatitis C virus RNA-dependent RNA polymerase.

Dhanak D, Duffy KJ, Johnston VK, Lin-Goerke J, Darcy M, Shaw AN, Gu B, Silverman C, Gates AT, Nonnemacher MR, Earnshaw DL, Casper DJ, Kaura A, Baker A, Greenwood C, Gutshall LL, Maley D, DelVecchio A, Macarron R, Hofmann GA, Alnoah Z, Cheng HY, Chan G, Khandekar S, Keenan RM, Sarisky RT. Dhanak D, et al. Among authors: macarron r. J Biol Chem. 2002 Oct 11;277(41):38322-7. doi: 10.1074/jbc.M205566200. Epub 2002 Aug 6. J Biol Chem. 2002. PMID: 12167642 Free article.

10

Identification of novel isoform-selective inhibitors within class I histone deacetylases.

Hu E, Dul E, Sung CM, Chen Z, Kirkpatrick R, Zhang GF, Johanson K, Liu R, Lago A, Hofmann G, Macarron R, de los Frailes M, Perez P, Krawiec J, Winkler J, Jaye M. Hu E, et al. Among authors: macarron r. J Pharmacol Exp Ther. 2003 Nov;307(2):720-8. doi: 10.1124/jpet.103.055541. Epub 2003 Sep 15. J Pharmacol Exp Ther. 2003. PMID: 12975486

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page